3 minutes agoAn anticonvid vaccine faster than we imagined on the market
Periskopi(6 years ago)
(6 years ago)The antibody vaccine could be distributed to Europe, starting in mid-December. The news was released by Bitonech's chief executive, following the announcement that Pfizer's vaccine and Bitetech could provide a protection of up to 95% from the Devid-19 virus. He stressed that everything depends also on requests to be taken on [...]
The antibody vaccine could be distributed to Europe, starting in mid-December.
The news was released by Bitonech's chief executive, following the announcement that Pfizer's vaccine and Bitetech could provide a protection of up to 95% from the Devid-19 virus.
He pointed out that everything depends also on demands regarding the vaccine.
If we make an optimistic account in Europe, the vaccine can be approved in the second half of December. It will depend on the demands we receive and on whether conditions have been met. In the United States, approval is possible at the end of the first half of December. We've been monitoring 95%, protection from disease”, said Ugur Sahin, Chief Executive of Biotech.
Just as officials and private companies are willing to distribute vaccines
